Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Intravenous (IV) Ibuprofen Market Growth 2022-2028

  • LP 4801474
  • 106 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Intravenous (IV) Ibuprofen will have significant change from previous year. According to our (LP Information) latest study, the global Intravenous (IV) Ibuprofen market size is USD million in 2022 from USD 6893.4 million in 2021, with a change of % between 2021 and 2022. The global Intravenous (IV) Ibuprofen market size will reach USD 14980 million in 2028, growing at a CAGR of 11.7% over the analysis period.

The United States Intravenous (IV) Ibuprofen market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Intravenous (IV) Ibuprofen market, reaching US$ million by the year 2028. As for the Europe Intravenous (IV) Ibuprofen landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Intravenous (IV) Ibuprofen players cover Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited, and Sandor Medicaids, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous (IV) Ibuprofen market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

100 mg Dose

200 mg Dose

400 mg Dose

800 mg Dose

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Pain

Fever

Inflammation

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Cumberland Pharmaceuticals

Alveda Pharmaceuticals

CSL Limited

Sandor Medicaids

PT. Soho Industri Pharmasi

Germin MED

Grifols

Gloria Pharmaceuticals

Al Nabeel International

Laboratorios Valmorca

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Intravenous (IV) Ibuprofen Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Intravenous (IV) Ibuprofen by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Intravenous (IV) Ibuprofen by Country/Region, 2017, 2022 & 2028

2.2 Intravenous (IV) Ibuprofen Segment by Type

2.2.1 100 mg Dose

2.2.2 200 mg Dose

2.2.3 400 mg Dose

2.2.4 800 mg Dose

2.3 Intravenous (IV) Ibuprofen Sales by Type

2.3.1 Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)

2.3.2 Global Intravenous (IV) Ibuprofen Revenue and Market Share by Type (2017-2022)

2.3.3 Global Intravenous (IV) Ibuprofen Sale Price by Type (2017-2022)

2.4 Intravenous (IV) Ibuprofen Segment by Application

2.4.1 Pain

2.4.2 Fever

2.4.3 Inflammation

2.5 Intravenous (IV) Ibuprofen Sales by Application

2.5.1 Global Intravenous (IV) Ibuprofen Sale Market Share by Application (2017-2022)

2.5.2 Global Intravenous (IV) Ibuprofen Revenue and Market Share by Application (2017-2022)

2.5.3 Global Intravenous (IV) Ibuprofen Sale Price by Application (2017-2022)

3 Global Intravenous (IV) Ibuprofen by Company

3.1 Global Intravenous (IV) Ibuprofen Breakdown Data by Company

3.1.1 Global Intravenous (IV) Ibuprofen Annual Sales by Company (2020-2022)

3.1.2 Global Intravenous (IV) Ibuprofen Sales Market Share by Company (2020-2022)

3.2 Global Intravenous (IV) Ibuprofen Annual Revenue by Company (2020-2022)

3.2.1 Global Intravenous (IV) Ibuprofen Revenue by Company (2020-2022)

3.2.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Company (2020-2022)

3.3 Global Intravenous (IV) Ibuprofen Sale Price by Company

3.4 Key Manufacturers Intravenous (IV) Ibuprofen Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Intravenous (IV) Ibuprofen Product Location Distribution

3.4.2 Players Intravenous (IV) Ibuprofen Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Intravenous (IV) Ibuprofen by Geographic Region

4.1 World Historic Intravenous (IV) Ibuprofen Market Size by Geographic Region (2017-2022)

4.1.1 Global Intravenous (IV) Ibuprofen Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Intravenous (IV) Ibuprofen Annual Revenue by Geographic Region

4.2 World Historic Intravenous (IV) Ibuprofen Market Size by Country/Region (2017-2022)

4.2.1 Global Intravenous (IV) Ibuprofen Annual Sales by Country/Region (2017-2022)

4.2.2 Global Intravenous (IV) Ibuprofen Annual Revenue by Country/Region

4.3 Americas Intravenous (IV) Ibuprofen Sales Growth

4.4 APAC Intravenous (IV) Ibuprofen Sales Growth

4.5 Europe Intravenous (IV) Ibuprofen Sales Growth

4.6 Middle East & Africa Intravenous (IV) Ibuprofen Sales Growth

5 Americas

5.1 Americas Intravenous (IV) Ibuprofen Sales by Country

5.1.1 Americas Intravenous (IV) Ibuprofen Sales by Country (2017-2022)

5.1.2 Americas Intravenous (IV) Ibuprofen Revenue by Country (2017-2022)

5.2 Americas Intravenous (IV) Ibuprofen Sales by Type

5.3 Americas Intravenous (IV) Ibuprofen Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Intravenous (IV) Ibuprofen Sales by Region

6.1.1 APAC Intravenous (IV) Ibuprofen Sales by Region (2017-2022)

6.1.2 APAC Intravenous (IV) Ibuprofen Revenue by Region (2017-2022)

6.2 APAC Intravenous (IV) Ibuprofen Sales by Type

6.3 APAC Intravenous (IV) Ibuprofen Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Intravenous (IV) Ibuprofen by Country

7.1.1 Europe Intravenous (IV) Ibuprofen Sales by Country (2017-2022)

7.1.2 Europe Intravenous (IV) Ibuprofen Revenue by Country (2017-2022)

7.2 Europe Intravenous (IV) Ibuprofen Sales by Type

7.3 Europe Intravenous (IV) Ibuprofen Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Intravenous (IV) Ibuprofen by Country

8.1.1 Middle East & Africa Intravenous (IV) Ibuprofen Sales by Country (2017-2022)

8.1.2 Middle East & Africa Intravenous (IV) Ibuprofen Revenue by Country (2017-2022)

8.2 Middle East & Africa Intravenous (IV) Ibuprofen Sales by Type

8.3 Middle East & Africa Intravenous (IV) Ibuprofen Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Intravenous (IV) Ibuprofen

10.3 Manufacturing Process Analysis of Intravenous (IV) Ibuprofen

10.4 Industry Chain Structure of Intravenous (IV) Ibuprofen

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Intravenous (IV) Ibuprofen Distributors

11.3 Intravenous (IV) Ibuprofen Customer

12 World Forecast Review for Intravenous (IV) Ibuprofen by Geographic Region

12.1 Global Intravenous (IV) Ibuprofen Market Size Forecast by Region

12.1.1 Global Intravenous (IV) Ibuprofen Forecast by Region (2023-2028)

12.1.2 Global Intravenous (IV) Ibuprofen Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Intravenous (IV) Ibuprofen Forecast by Type

12.7 Global Intravenous (IV) Ibuprofen Forecast by Application

13 Key Players Analysis

13.1 Cumberland Pharmaceuticals

13.1.1 Cumberland Pharmaceuticals Company Information

13.1.2 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered

13.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Cumberland Pharmaceuticals Main Business Overview

13.1.5 Cumberland Pharmaceuticals Latest Developments

13.2 Alveda Pharmaceuticals

13.2.1 Alveda Pharmaceuticals Company Information

13.2.2 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered

13.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Alveda Pharmaceuticals Main Business Overview

13.2.5 Alveda Pharmaceuticals Latest Developments

13.3 CSL Limited

13.3.1 CSL Limited Company Information

13.3.2 CSL Limited Intravenous (IV) Ibuprofen Product Offered

13.3.3 CSL Limited Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 CSL Limited Main Business Overview

13.3.5 CSL Limited Latest Developments

13.4 Sandor Medicaids

13.4.1 Sandor Medicaids Company Information

13.4.2 Sandor Medicaids Intravenous (IV) Ibuprofen Product Offered

13.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sandor Medicaids Main Business Overview

13.4.5 Sandor Medicaids Latest Developments

13.5 PT. Soho Industri Pharmasi

13.5.1 PT. Soho Industri Pharmasi Company Information

13.5.2 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product Offered

13.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 PT. Soho Industri Pharmasi Main Business Overview

13.5.5 PT. Soho Industri Pharmasi Latest Developments

13.6 Germin MED

13.6.1 Germin MED Company Information

13.6.2 Germin MED Intravenous (IV) Ibuprofen Product Offered

13.6.3 Germin MED Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Germin MED Main Business Overview

13.6.5 Germin MED Latest Developments

13.7 Grifols

13.7.1 Grifols Company Information

13.7.2 Grifols Intravenous (IV) Ibuprofen Product Offered

13.7.3 Grifols Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Grifols Main Business Overview

13.7.5 Grifols Latest Developments

13.8 Gloria Pharmaceuticals

13.8.1 Gloria Pharmaceuticals Company Information

13.8.2 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered

13.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Gloria Pharmaceuticals Main Business Overview

13.8.5 Gloria Pharmaceuticals Latest Developments

13.9 Al Nabeel International

13.9.1 Al Nabeel International Company Information

13.9.2 Al Nabeel International Intravenous (IV) Ibuprofen Product Offered

13.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Al Nabeel International Main Business Overview

13.9.5 Al Nabeel International Latest Developments

13.10 Laboratorios Valmorca

13.10.1 Laboratorios Valmorca Company Information

13.10.2 Laboratorios Valmorca Intravenous (IV) Ibuprofen Product Offered

13.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Laboratorios Valmorca Main Business Overview

13.10.5 Laboratorios Valmorca Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Intravenous (IV) Ibuprofen Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Intravenous (IV) Ibuprofen Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 100 mg Dose

Table 4. Major Players of 200 mg Dose

Table 5. Major Players of 400 mg Dose

Table 6. Major Players of 800 mg Dose

Table 7. Global Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)

Table 8. Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)

Table 9. Global Intravenous (IV) Ibuprofen Revenue by Type (2017-2022) & ($ million)

Table 10. Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2017-2022)

Table 11. Global Intravenous (IV) Ibuprofen Sale Price by Type (2017-2022) & (USD/Kg)

Table 12. Global Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)

Table 13. Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2022)

Table 14. Global Intravenous (IV) Ibuprofen Revenue by Application (2017-2022)

Table 15. Global Intravenous (IV) Ibuprofen Revenue Market Share by Application (2017-2022)

Table 16. Global Intravenous (IV) Ibuprofen Sale Price by Application (2017-2022) & (USD/Kg)

Table 17. Global Intravenous (IV) Ibuprofen Sales by Company (2020-2022) & (MT)

Table 18. Global Intravenous (IV) Ibuprofen Sales Market Share by Company (2020-2022)

Table 19. Global Intravenous (IV) Ibuprofen Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Intravenous (IV) Ibuprofen Revenue Market Share by Company (2020-2022)

Table 21. Global Intravenous (IV) Ibuprofen Sale Price by Company (2020-2022) & (USD/Kg)

Table 22. Key Manufacturers Intravenous (IV) Ibuprofen Producing Area Distribution and Sales Area

Table 23. Players Intravenous (IV) Ibuprofen Products Offered

Table 24. Intravenous (IV) Ibuprofen Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Intravenous (IV) Ibuprofen Sales by Geographic Region (2017-2022) & (MT)

Table 28. Global Intravenous (IV) Ibuprofen Sales Market Share Geographic Region (2017-2022)

Table 29. Global Intravenous (IV) Ibuprofen Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Intravenous (IV) Ibuprofen Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Intravenous (IV) Ibuprofen Sales by Country/Region (2017-2022) & (MT)

Table 32. Global Intravenous (IV) Ibuprofen Sales Market Share by Country/Region (2017-2022)

Table 33. Global Intravenous (IV) Ibuprofen Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Intravenous (IV) Ibuprofen Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Intravenous (IV) Ibuprofen Sales by Country (2017-2022) & (MT)

Table 36. Americas Intravenous (IV) Ibuprofen Sales Market Share by Country (2017-2022)

Table 37. Americas Intravenous (IV) Ibuprofen Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Intravenous (IV) Ibuprofen Revenue Market Share by Country (2017-2022)

Table 39. Americas Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)

Table 40. Americas Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)

Table 41. Americas Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)

Table 42. Americas Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2022)

Table 43. APAC Intravenous (IV) Ibuprofen Sales by Region (2017-2022) & (MT)

Table 44. APAC Intravenous (IV) Ibuprofen Sales Market Share by Region (2017-2022)

Table 45. APAC Intravenous (IV) Ibuprofen Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Intravenous (IV) Ibuprofen Revenue Market Share by Region (2017-2022)

Table 47. APAC Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)

Table 48. APAC Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)

Table 49. APAC Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)

Table 50. APAC Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2022)

Table 51. Europe Intravenous (IV) Ibuprofen Sales by Country (2017-2022) & (MT)

Table 52. Europe Intravenous (IV) Ibuprofen Sales Market Share by Country (2017-2022)

Table 53. Europe Intravenous (IV) Ibuprofen Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Intravenous (IV) Ibuprofen Revenue Market Share by Country (2017-2022)

Table 55. Europe Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)

Table 56. Europe Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)

Table 57. Europe Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)

Table 58. Europe Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Intravenous (IV) Ibuprofen Sales by Country (2017-2022) & (MT)

Table 60. Middle East & Africa Intravenous (IV) Ibuprofen Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Intravenous (IV) Ibuprofen Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Intravenous (IV) Ibuprofen Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)

Table 64. Middle East & Africa Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)

Table 66. Middle East & Africa Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Intravenous (IV) Ibuprofen

Table 68. Key Market Challenges & Risks of Intravenous (IV) Ibuprofen

Table 69. Key Industry Trends of Intravenous (IV) Ibuprofen

Table 70. Intravenous (IV) Ibuprofen Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Intravenous (IV) Ibuprofen Distributors List

Table 73. Intravenous (IV) Ibuprofen Customer List

Table 74. Global Intravenous (IV) Ibuprofen Sales Forecast by Region (2023-2028) & (MT)

Table 75. Global Intravenous (IV) Ibuprofen Sales Market Forecast by Region

Table 76. Global Intravenous (IV) Ibuprofen Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Intravenous (IV) Ibuprofen Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Intravenous (IV) Ibuprofen Sales Forecast by Country (2023-2028) & (MT)

Table 79. Americas Intravenous (IV) Ibuprofen Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Intravenous (IV) Ibuprofen Sales Forecast by Region (2023-2028) & (MT)

Table 81. APAC Intravenous (IV) Ibuprofen Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Intravenous (IV) Ibuprofen Sales Forecast by Country (2023-2028) & (MT)

Table 83. Europe Intravenous (IV) Ibuprofen Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Intravenous (IV) Ibuprofen Sales Forecast by Country (2023-2028) & (MT)

Table 85. Middle East & Africa Intravenous (IV) Ibuprofen Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Intravenous (IV) Ibuprofen Sales Forecast by Type (2023-2028) & (MT)

Table 87. Global Intravenous (IV) Ibuprofen Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Intravenous (IV) Ibuprofen Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Intravenous (IV) Ibuprofen Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Intravenous (IV) Ibuprofen Sales Forecast by Application (2023-2028) & (MT)

Table 91. Global Intravenous (IV) Ibuprofen Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Intravenous (IV) Ibuprofen Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Intravenous (IV) Ibuprofen Revenue Market Share Forecast by Application (2023-2028)

Table 94. Cumberland Pharmaceuticals Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors

Table 95. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered

Table 96. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 97. Cumberland Pharmaceuticals Main Business

Table 98. Cumberland Pharmaceuticals Latest Developments

Table 99. Alveda Pharmaceuticals Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors

Table 100. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered

Table 101. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 102. Alveda Pharmaceuticals Main Business

Table 103. Alveda Pharmaceuticals Latest Developments

Table 104. CSL Limited Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors

Table 105. CSL Limited Intravenous (IV) Ibuprofen Product Offered

Table 106. CSL Limited Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 107. CSL Limited Main Business

Table 108. CSL Limited Latest Developments

Table 109. Sandor Medicaids Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors

Table 110. Sandor Medicaids Intravenous (IV) Ibuprofen Product Offered

Table 111. Sandor Medicaids Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 112. Sandor Medicaids Main Business

Table 113. Sandor Medicaids Latest Developments

Table 114. PT. Soho Industri Pharmasi Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors

Table 115. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product Offered

Table 116. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 117. PT. Soho Industri Pharmasi Main Business

Table 118. PT. Soho Industri Pharmasi Latest Developments

Table 119. Germin MED Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors

Table 120. Germin MED Intravenous (IV) Ibuprofen Product Offered

Table 121. Germin MED Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 122. Germin MED Main Business

Table 123. Germin MED Latest Developments

Table 124. Grifols Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors

Table 125. Grifols Intravenous (IV) Ibuprofen Product Offered

Table 126. Grifols Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 127. Grifols Main Business

Table 128. Grifols Latest Developments

Table 129. Gloria Pharmaceuticals Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors

Table 130. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered

Table 131. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 132. Gloria Pharmaceuticals Main Business

Table 133. Gloria Pharmaceuticals Latest Developments

Table 134. Al Nabeel International Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors

Table 135. Al Nabeel International Intravenous (IV) Ibuprofen Product Offered

Table 136. Al Nabeel International Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 137. Al Nabeel International Main Business

Table 138. Al Nabeel International Latest Developments

Table 139. Laboratorios Valmorca Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors

Table 140. Laboratorios Valmorca Intravenous (IV) Ibuprofen Product Offered

Table 141. Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 142. Laboratorios Valmorca Main Business

Table 143. Laboratorios Valmorca Latest Developments

List of Figures

Figure 1. Picture of Intravenous (IV) Ibuprofen

Figure 2. Intravenous (IV) Ibuprofen Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Intravenous (IV) Ibuprofen Sales Growth Rate 2017-2028 (MT)

Figure 7. Global Intravenous (IV) Ibuprofen Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Intravenous (IV) Ibuprofen Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 100 mg Dose

Figure 10. Product Picture of 200 mg Dose

Figure 11. Product Picture of 400 mg Dose

Figure 12. Product Picture of 800 mg Dose

Figure 13. Global Intravenous (IV) Ibuprofen Sales Market Share by Type in 2021

Figure 14. Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2017-2022)

Figure 15. Intravenous (IV) Ibuprofen Consumed in Pain

Figure 16. Global Intravenous (IV) Ibuprofen Market: Pain (2017-2022) & (MT)

Figure 17. Intravenous (IV) Ibuprofen Consumed in Fever

Figure 18. Global Intravenous (IV) Ibuprofen Market: Fever (2017-2022) & (MT)

Figure 19. Intravenous (IV) Ibuprofen Consumed in Inflammation

Figure 20. Global Intravenous (IV) Ibuprofen Market: Inflammation (2017-2022) & (MT)

Figure 21. Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2022)

Figure 22. Global Intravenous (IV) Ibuprofen Revenue Market Share by Application in 2021

Figure 23. Intravenous (IV) Ibuprofen Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Intravenous (IV) Ibuprofen Revenue Market Share by Company in 2021

Figure 25. Global Intravenous (IV) Ibuprofen Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Intravenous (IV) Ibuprofen Revenue Market Share by Geographic Region in 2021

Figure 27. Global Intravenous (IV) Ibuprofen Sales Market Share by Region (2017-2022)

Figure 28. Global Intravenous (IV) Ibuprofen Revenue Market Share by Country/Region in 2021

Figure 29. Americas Intravenous (IV) Ibuprofen Sales 2017-2022 (MT)

Figure 30. Americas Intravenous (IV) Ibuprofen Revenue 2017-2022 ($ Millions)

Figure 31. APAC Intravenous (IV) Ibuprofen Sales 2017-2022 (MT)

Figure 32. APAC Intravenous (IV) Ibuprofen Revenue 2017-2022 ($ Millions)

Figure 33. Europe Intravenous (IV) Ibuprofen Sales 2017-2022 (MT)

Figure 34. Europe Intravenous (IV) Ibuprofen Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Intravenous (IV) Ibuprofen Sales 2017-2022 (MT)

Figure 36. Middle East & Africa Intravenous (IV) Ibuprofen Revenue 2017-2022 ($ Millions)

Figure 37. Americas Intravenous (IV) Ibuprofen Sales Market Share by Country in 2021

Figure 38. Americas Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2021

Figure 39. United States Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Intravenous (IV) Ibuprofen Sales Market Share by Region in 2021

Figure 44. APAC Intravenous (IV) Ibuprofen Revenue Market Share by Regions in 2021

Figure 45. China Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Intravenous (IV) Ibuprofen Sales Market Share by Country in 2021

Figure 52. Europe Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2021

Figure 53. Germany Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Intravenous (IV) Ibuprofen Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2021

Figure 60. Egypt Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Intravenous (IV) Ibuprofen in 2021

Figure 66. Manufacturing Process Analysis of Intravenous (IV) Ibuprofen

Figure 67. Industry Chain Structure of Intravenous (IV) Ibuprofen

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390